Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI

Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 1993-02, Vol.34 (2), p.173-179
Hauptverfasser: Maurea, Simone, Cuocolo, Alberto, Reynolds, James C, Tumeh, Sabah S, Begley, Martin G, Linehan, W. Marston, Norton, Jeffrey A, Walther, McClellan M, Keiser, Harry R, Neumann, Ronald D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 179
container_issue 2
container_start_page 173
container_title The Journal of nuclear medicine (1978)
container_volume 34
creator Maurea, Simone
Cuocolo, Alberto
Reynolds, James C
Tumeh, Sabah S
Begley, Martin G
Linehan, W. Marston
Norton, Jeffrey A
Walther, McClellan M
Keiser, Harry R
Neumann, Ronald D
description Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75593034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75593034</sourcerecordid><originalsourceid>FETCH-LOGICAL-h237t-99282be25c928256c28daa76727fd4ab07587670bc8d335d8f34a639c2b2feed3</originalsourceid><addsrcrecordid>eNpFkNFOgzAUhonRzDl9BJNeeUcCLaXFO0OmLtniovOaHGiBLtBiC1vmK_jSMl2yq_Of83_5Ls6FNw0poT6NY3bpTYMwDn1KA3rt3Ti3DYIg5pxPvAknPIxYNPV-FkYoLX0UktBfyR6UESaX-vvQVANodSzRR6F0ryoLXX1ASqO1laaTFnq1kwi0QGvj-vNlvoNmGKPRyJRoDRYq0FWjTAvuEaWm7cAqN7Z71dco3fwpVu-LW--qhMbJu9OceZ_P80366i_fXhbp09KvMWG9nySY41xiWhwDjQvMBQCLGWaliCAPGOXjFuQFF4RQwUsSQUySAue4lFKQmffw7-2s-Rqk67NWuUI2DWhpBpcxShMSkGgE70_gkLdSZJ1VLdhDdvreWVSrqt4rKzM9FI0Ee4S3uiVRhrOQEfILbmV70g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75593034</pqid></control><display><type>article</type><title>Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Maurea, Simone ; Cuocolo, Alberto ; Reynolds, James C ; Tumeh, Sabah S ; Begley, Martin G ; Linehan, W. Marston ; Norton, Jeffrey A ; Walther, McClellan M ; Keiser, Harry R ; Neumann, Ronald D</creator><creatorcontrib>Maurea, Simone ; Cuocolo, Alberto ; Reynolds, James C ; Tumeh, Sabah S ; Begley, Martin G ; Linehan, W. Marston ; Norton, Jeffrey A ; Walther, McClellan M ; Keiser, Harry R ; Neumann, Ronald D</creatorcontrib><description>Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>PMID: 8381474</identifier><language>eng</language><publisher>United States: Soc Nuclear Med</publisher><subject>3-Iodobenzylguanidine ; Adrenal Gland Neoplasms - diagnosis ; Adrenal Gland Neoplasms - diagnostic imaging ; Adrenal Gland Neoplasms - surgery ; Adult ; Female ; Humans ; Iodine Radioisotopes ; Iodobenzenes ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Paraganglioma - diagnosis ; Paraganglioma - diagnostic imaging ; Paraganglioma - surgery ; Paraganglioma, Extra-Adrenal - diagnosis ; Paraganglioma, Extra-Adrenal - diagnostic imaging ; Paraganglioma, Extra-Adrenal - surgery ; Radionuclide Imaging ; Tomography, X-Ray Computed</subject><ispartof>The Journal of nuclear medicine (1978), 1993-02, Vol.34 (2), p.173-179</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8381474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maurea, Simone</creatorcontrib><creatorcontrib>Cuocolo, Alberto</creatorcontrib><creatorcontrib>Reynolds, James C</creatorcontrib><creatorcontrib>Tumeh, Sabah S</creatorcontrib><creatorcontrib>Begley, Martin G</creatorcontrib><creatorcontrib>Linehan, W. Marston</creatorcontrib><creatorcontrib>Norton, Jeffrey A</creatorcontrib><creatorcontrib>Walther, McClellan M</creatorcontrib><creatorcontrib>Keiser, Harry R</creatorcontrib><creatorcontrib>Neumann, Ronald D</creatorcontrib><title>Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI</title><title>The Journal of nuclear medicine (1978)</title><addtitle>J Nucl Med</addtitle><description>Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.</description><subject>3-Iodobenzylguanidine</subject><subject>Adrenal Gland Neoplasms - diagnosis</subject><subject>Adrenal Gland Neoplasms - diagnostic imaging</subject><subject>Adrenal Gland Neoplasms - surgery</subject><subject>Adult</subject><subject>Female</subject><subject>Humans</subject><subject>Iodine Radioisotopes</subject><subject>Iodobenzenes</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Paraganglioma - diagnosis</subject><subject>Paraganglioma - diagnostic imaging</subject><subject>Paraganglioma - surgery</subject><subject>Paraganglioma, Extra-Adrenal - diagnosis</subject><subject>Paraganglioma, Extra-Adrenal - diagnostic imaging</subject><subject>Paraganglioma, Extra-Adrenal - surgery</subject><subject>Radionuclide Imaging</subject><subject>Tomography, X-Ray Computed</subject><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkNFOgzAUhonRzDl9BJNeeUcCLaXFO0OmLtniovOaHGiBLtBiC1vmK_jSMl2yq_Of83_5Ls6FNw0poT6NY3bpTYMwDn1KA3rt3Ti3DYIg5pxPvAknPIxYNPV-FkYoLX0UktBfyR6UESaX-vvQVANodSzRR6F0ryoLXX1ASqO1laaTFnq1kwi0QGvj-vNlvoNmGKPRyJRoDRYq0FWjTAvuEaWm7cAqN7Z71dco3fwpVu-LW--qhMbJu9OceZ_P80366i_fXhbp09KvMWG9nySY41xiWhwDjQvMBQCLGWaliCAPGOXjFuQFF4RQwUsSQUySAue4lFKQmffw7-2s-Rqk67NWuUI2DWhpBpcxShMSkGgE70_gkLdSZJ1VLdhDdvreWVSrqt4rKzM9FI0Ee4S3uiVRhrOQEfILbmV70g</recordid><startdate>19930201</startdate><enddate>19930201</enddate><creator>Maurea, Simone</creator><creator>Cuocolo, Alberto</creator><creator>Reynolds, James C</creator><creator>Tumeh, Sabah S</creator><creator>Begley, Martin G</creator><creator>Linehan, W. Marston</creator><creator>Norton, Jeffrey A</creator><creator>Walther, McClellan M</creator><creator>Keiser, Harry R</creator><creator>Neumann, Ronald D</creator><general>Soc Nuclear Med</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19930201</creationdate><title>Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI</title><author>Maurea, Simone ; Cuocolo, Alberto ; Reynolds, James C ; Tumeh, Sabah S ; Begley, Martin G ; Linehan, W. Marston ; Norton, Jeffrey A ; Walther, McClellan M ; Keiser, Harry R ; Neumann, Ronald D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h237t-99282be25c928256c28daa76727fd4ab07587670bc8d335d8f34a639c2b2feed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>3-Iodobenzylguanidine</topic><topic>Adrenal Gland Neoplasms - diagnosis</topic><topic>Adrenal Gland Neoplasms - diagnostic imaging</topic><topic>Adrenal Gland Neoplasms - surgery</topic><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Iodine Radioisotopes</topic><topic>Iodobenzenes</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Paraganglioma - diagnosis</topic><topic>Paraganglioma - diagnostic imaging</topic><topic>Paraganglioma - surgery</topic><topic>Paraganglioma, Extra-Adrenal - diagnosis</topic><topic>Paraganglioma, Extra-Adrenal - diagnostic imaging</topic><topic>Paraganglioma, Extra-Adrenal - surgery</topic><topic>Radionuclide Imaging</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maurea, Simone</creatorcontrib><creatorcontrib>Cuocolo, Alberto</creatorcontrib><creatorcontrib>Reynolds, James C</creatorcontrib><creatorcontrib>Tumeh, Sabah S</creatorcontrib><creatorcontrib>Begley, Martin G</creatorcontrib><creatorcontrib>Linehan, W. Marston</creatorcontrib><creatorcontrib>Norton, Jeffrey A</creatorcontrib><creatorcontrib>Walther, McClellan M</creatorcontrib><creatorcontrib>Keiser, Harry R</creatorcontrib><creatorcontrib>Neumann, Ronald D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maurea, Simone</au><au>Cuocolo, Alberto</au><au>Reynolds, James C</au><au>Tumeh, Sabah S</au><au>Begley, Martin G</au><au>Linehan, W. Marston</au><au>Norton, Jeffrey A</au><au>Walther, McClellan M</au><au>Keiser, Harry R</au><au>Neumann, Ronald D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><addtitle>J Nucl Med</addtitle><date>1993-02-01</date><risdate>1993</risdate><volume>34</volume><issue>2</issue><spage>173</spage><epage>179</epage><pages>173-179</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><abstract>Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.</abstract><cop>United States</cop><pub>Soc Nuclear Med</pub><pmid>8381474</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-5505
ispartof The Journal of nuclear medicine (1978), 1993-02, Vol.34 (2), p.173-179
issn 0161-5505
1535-5667
language eng
recordid cdi_proquest_miscellaneous_75593034
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects 3-Iodobenzylguanidine
Adrenal Gland Neoplasms - diagnosis
Adrenal Gland Neoplasms - diagnostic imaging
Adrenal Gland Neoplasms - surgery
Adult
Female
Humans
Iodine Radioisotopes
Iodobenzenes
Magnetic Resonance Imaging
Male
Middle Aged
Paraganglioma - diagnosis
Paraganglioma - diagnostic imaging
Paraganglioma - surgery
Paraganglioma, Extra-Adrenal - diagnosis
Paraganglioma, Extra-Adrenal - diagnostic imaging
Paraganglioma, Extra-Adrenal - surgery
Radionuclide Imaging
Tomography, X-Ray Computed
title Iodine- 131-Metaiodobenzylguanidine Scintigraphy in Preoperative and Postoperative Evaluation of Paragangliomas: Comparison with CT and MRI
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T23%3A28%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Iodine-%20131-Metaiodobenzylguanidine%20Scintigraphy%20in%20Preoperative%20and%20Postoperative%20Evaluation%20of%20Paragangliomas:%20Comparison%20with%20CT%20and%20MRI&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Maurea,%20Simone&rft.date=1993-02-01&rft.volume=34&rft.issue=2&rft.spage=173&rft.epage=179&rft.pages=173-179&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E75593034%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75593034&rft_id=info:pmid/8381474&rfr_iscdi=true